Document is current
Any future updates will be listed below
-
Authors
Maniou, Eirini https://orcid.org/0000-0001-9419-7374
Todros, Silvia https://orcid.org/0000-0002-6077-9672
Urciuolo, Anna https://orcid.org/0000-0001-7571-9747
Moulding, Dale A. https://orcid.org/0000-0002-1431-7047
Magnussen, Michael https://orcid.org/0000-0003-3054-9806
Ampartzidis, Ioakeim https://orcid.org/0000-0002-2856-3396
Brandolino, Luca
Bellet, Pietro
Giomo, Monica https://orcid.org/0000-0002-7690-1054
Pavan, Piero G. https://orcid.org/0000-0002-3875-9640
Galea, Gabriel L. https://orcid.org/0000-0003-2515-1342
Elvassore, Nicola https://orcid.org/0000-0002-7029-6287
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova (Twining)
University of Padova, Progetti di Eccellenza Cariparo, TWINING of University of Padova, Oak Foundation Award.
- License Information
-
More Information
Article History
Received: 18 January 2022
Accepted: 5 June 2024
First Online: 5 July 2024
Competing interests
: N.E. has an equity stake in ONYEL Biotech s.r.l. N.E. and A.U. are inventors of a patent for the use of HCC-hydrogels (patent applicant, ONYEL Biotech s.r.l.; patent number EP4138941). All other authors have no competing interests.
